bioAffinity Technologies, Inc. Annual Operating Income (Loss) in USD from 2021 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
bioAffinity Technologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2024.
  • bioAffinity Technologies, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$2.95M, a 25.8% decline year-over-year.
  • bioAffinity Technologies, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$8.95M, a 12.3% decline year-over-year.
  • bioAffinity Technologies, Inc. annual Operating Income (Loss) for 2024 was -$8.95M, a 12.3% decline from 2023.
  • bioAffinity Technologies, Inc. annual Operating Income (Loss) for 2023 was -$7.97M, a 98.8% decline from 2022.
  • bioAffinity Technologies, Inc. annual Operating Income (Loss) for 2022 was -$4.01M, a 81.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$8.95M -$980K -12.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$7.97M -$3.96M -98.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$4.01M -$1.8M -81.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$2.21M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.